Beneficial Effects of Protocatechuic Acid on Diabetic Retinopathy in Streptozocin-induced Diabetic Rats
Overview
Authors
Affiliations
Aim: To determine the effects of protocatechuic acid (PCA) on streptozocin-induced diabetic retinopathy (DR) in rats.
Methods: Wistar rats were given a 50 mg/kg intraperitoneal injection of streptozocin to induce diabetes. Animals were assigned randomly one of four groups (8 rats per group): control, diabetic, diabetic plus PCA (25 mg/kg·d), and diabetic plus PCA (50 mg/kg·d). After inducing diabetes, treatments were started one week later and continued for eight weeks. After the experiment, the rats were sacrificed, and their retinas were taken for biochemical and molecular analysis.
Results: PCA administration diminished the blood glucose and glycated haemoglobin levels relative to the diabetic group. In diabetic rats, PCA lowered elevated levels of advanced glycosylated end products (AGEs) and receptor for AGEs (RAGE). In the retina of diabetic rats, PCA effectively decreased inflammatory cytokine, nuclear factor-κB, tumour necrosis factor-α, interleukin-1β, and vascular endothelial growth factor, and increased antioxidant markers glutathione, superoxide dismutase, and catalase.
Conclusion: The protective benefits of PCA against DR may be attributable to its suppression of the AGEs and RAGE and its antioxidant and anti-inflammatory properties.
Mechanisms of gut bacterial metabolism of dietary polyphenols into bioactive compounds.
Alqudah S, Claesen J Gut Microbes. 2024; 16(1):2426614.
PMID: 39540668 PMC: 11572103. DOI: 10.1080/19490976.2024.2426614.
Kiriyama Y, Tokumaru H, Sadamoto H, Kobayashi S, Nochi H Molecules. 2024; 29(21).
PMID: 39519743 PMC: 11548037. DOI: 10.3390/molecules29215102.
Zhang Y, Liu X, Zhai X, Yao Y, Shao B, Zhen Y Int J Ophthalmol. 2024; 17(8):1403-1410.
PMID: 39156790 PMC: 11286436. DOI: 10.18240/ijo.2024.08.03.
Glycative stress as a cause of macular degeneration.
Bejarano E, Domenech-Bendana A, Avila-Portillo N, Rowan S, Edirisinghe S, Taylor A Prog Retin Eye Res. 2024; 101:101260.
PMID: 38521386 PMC: 11699537. DOI: 10.1016/j.preteyeres.2024.101260.
Saad K, Lopes Salles E, Naeini S, Baban B, Abdelmageed M, Abdelaziz R Pharmacol Rep. 2024; 76(1):98-111.
PMID: 38214881 DOI: 10.1007/s43440-023-00565-2.